Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Hanno Nieß

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0981-4049; OpenAlex author ID A5047396579. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 3 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 11

  1. Microbiome Dysbiosis With Enterococcus Presence in the Upper Gastrointestinal Tract Is a Risk Factor for Mortality in Patients Undergoing Surgery for Pancreati… Co-author DOI 10.1097/sla.0000000000006210↗
  2. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture. Co-author DOI 10.1007/s00432-023-05100-7↗
  3. WNT enhancing signals in pancreatic cancer are transmitted by LGR6. Co-author DOI 10.18632/aging.205101↗
  4. Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matche… Last author DOI 10.1186/s12893-021-01083-9↗
  5. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer. Co-author DOI 10.3390/cancers13112703↗
  6. Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An Update. Co-author DOI 10.1097/ppo.0000000000000372↗
  7. Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-017-2351-4↗
  8. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Co-author DOI 10.1007/s11523-014-0323-z↗
  9. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pa… Co-author DOI 10.1007/s11523-015-0360-2↗
  10. Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressiv… Co-author DOI 10.18632/oncotarget.2494↗
  11. [Pancreatic cancer in the elderly: guidelines and individualized therapy]. Co-author DOI 10.1007/s00104-012-2455-y↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bernhard Willibald Renz · 6 shared papers, 2019–2025 · strength 0.86
  2. Matthias Ilmer · 6 shared papers, 2019–2025 · strength 0.86
  3. Jens Werner · 5 shared papers, 2021–2025 · strength 0.75
  4. Iris Beirith · 4 shared papers, 2021–2025 · strength 0.63
  5. Jan Goesta D’Haese · 4 shared papers, 2019–2025 · strength 0.54
  6. Alexandr V. Bazhin · 3 shared papers, 2021–2023 · strength 0.43
  7. Christoph Benedikt Westphalen · 2 shared papers, 2019–2023 · strength 0.25
  8. Tengis Tschaidse · 1 shared paper, 2025 · strength 0.20
  9. Juliana de Castilhos · 1 shared paper, 2025 · strength 0.20
  10. Steffen Ormanns · 1 shared paper, 2025 · strength 0.20
  11. Christoph K. Stein‐Thoeringer · 1 shared paper, 2025 · strength 0.20
  12. Peter Čamaj · 4 shared papers, 2015–2017 · strength 0.20
  13. Christiane J. Bruns · 4 shared papers, 2015–2017 · strength 0.20
  14. Yue Zhao · 4 shared papers, 2015–2017 · strength 0.20
  15. Jing Wang · 1 shared paper, 2023 · strength 0.17
  16. Klaus‐Peter Janssen · 1 shared paper, 2023 · strength 0.17
  17. Ivonne Regel · 1 shared paper, 2023 · strength 0.15
  18. Simon Sirtl · 1 shared paper, 2023 · strength 0.15
  19. Maximilian Reichert · 1 shared paper, 2023 · strength 0.15
  20. Kathrin Heinrich · 1 shared paper, 2023 · strength 0.15
  21. M. Knoblauch · 1 shared paper, 2023 · strength 0.15
  22. Rainer Christoph Miksch · 1 shared paper, 2021 · strength 0.12
  23. Elise Pretzsch · 1 shared paper, 2021 · strength 0.12
  24. Jens Martin Werner · 1 shared paper, 2019 · strength 0.11
  25. Felix Popp · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.